KRMD Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
11.6M
-4.0%
12.0M
+2.4%
11.8M
+8.0%
10.9M
+4.7%
10.4M
Cost of Revenue
4.0M
-4.3%
4.2M
-7.4%
4.5M
+11.2%
4.1M
-1.4%
4.1M
Gross Profit
7.5M
-3.8%
7.8M
+8.5%
7.2M
+6.1%
6.8M
+8.8%
6.3M
Operating Expenses
7.4M
+1.9%
7.2M
-10.8%
8.1M
+9.9%
7.4M
+3.3%
7.1M
R&D
1.3M
+19.8%
1.1M
-18.8%
1.3M
+15.0%
1.1M
+22.7%
933.1K
SG&A
5.9M
-1.2%
5.9M
-9.8%
6.6M
+9.0%
6.0M
+0.8%
6.0M
Operating Income
187.1K
-70.2%
627.0K
+172.5%
-864923
-58.1%
-547104
+36.9%
-867679
EBITDA
397.1K
-52.6%
837.0K
+225.4%
-667392
-81.4%
-367930
+44.5%
-663197
Net Income
218.1K
-13.6%
252.4K
+131.3%
-807078
-65.8%
-486856
+37.4%
-777966
EPS (Basic)
$0.00
-100.0%
$0.01
+150.0%
$-0.02
-100.0%
$-0.01
+50.0%
$-0.02
EPS (Diluted)
$0.00
-100.0%
$0.01
+150.0%
$-0.02
-100.0%
$-0.01
+50.0%
$-0.02
Shares (Diluted)
46.7M
-5.6%
49.5M
+6.8%
46.4M
+0.1%
46.3M
+0.2%
46.2M
KORU Medical Systems, Inc. (DE) (KRMD) — Financials